Antipsychotic , Schizophrenia , Bipolar Disorder , Intra-Cellular Therapies , Sunovion Pharmaceuticals , Latuda Allergan, Vraylar, AbbVie , U.S. FDA , Caplyta by admin December 21, 2021 written by admin December 21, 2021 0 comment Share 0 FacebookTwitterPinterestEmail admin Leave a Comment Cancel ReplyYou must be logged in to post a comment. This site uses Akismet to reduce spam. Learn how your comment data is processed.